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Abstract. Cek9 is a receptor tyrosine kinase of the Eph 
subfamily for which only a partial cDNA sequence was 
known (Sajjadi, F.G., and E.B. Pasquale. 1993. Onco- 
gene. 8:1807-1813). We have obtained the entire cDNA 
sequence and identified a variant form of Cek9 that 
lacks a signal peptide. We subsequerttly examined the 
spatio-temporal expression and tyrosine phosphoryla- 
tion of Cek9 in the chicken embryo by using specific an- 
tibodies. At embryonic day 2, Cek9 immunoreactivity is 
concentrated in the eye, the brain, the posterior region 
of the neural tube, and the most recently formed 
somites. Later in development, Cek9 expression is 
widespread but particularly prominent in neural tissues. 
In the developing visual system, Cek9 is highly concen- 
trated in areas containing retinal ganglion cell axons, 
suggesting a role in regulating their outgrowth to the 
optic tectum. Unlike other Eph-related receptors, Cek9 
is substantially phosphorylated on tyrosine in many tis- 
sues at various developmental stages. Since autophos- 
phorylation of receptor protein-tyrosine kinases typi- 
cally correlates with increased enzymatic activity, this 
suggests that Cek9 plays an active role in embryonic 
signal transduction pathways. 
ECEPTOR protein-tyrosine kinases play critical roles 
in signal transduction pathways by relaying signals 
from the cell exterior to the interior. They accom- 
plish this by phosphorylating proteins on tyrosine. Recep- 
tor protein-tyrosine kinases are influenced by ligands, often 
polypeptide growth factors, that interact with the extracel- 
lular domain of the receptors, causing them to dimerize 
and autophosphorylate on tyrosine. Some of the autophos- 
phorylated  tyrosines  and  their  flanking  residues  form 
binding  sites  for  src  homology 2  (SH2)  or  phosphoty- 
rosine-binding (PTB) domains of target molecules, such as 
other kinases, substrates, or adaptor proteins (Blaikie et al., 
1994; Kavanaugh and Williams, 1994; van der Geer et al., 
1994). This in turn leads to the downstream activation of 
signaling molecules, ultimately causing cell proliferation, 
differentiation, migration, or  survival  (Schlessinger  and 
Ullrich, 1992; van der Geer et al., 1994), processes that are 
all important in embryogenesis. As a result, receptor pro- 
tein-tyrosine kinases, by serving as enzymes that catalyze 
phosphorylation of tyrosine residues, are likely to be in- 
volved in the formation of complex anatomical structures 
in the developing embryo. 
The Eph subfamily represents the largest group of re- 
ceptor protein-tyrosine kinases, comprised of at least 13 
distinct genes. The patterns of expression of members of 
the Eph subfamily during development suggest that these 
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kinases are important in pattern formation (Becker et al., 
1994; Ganju et al., 1994; Henkemeyer et al., 1994; Ruiz 
et al., 1994; Ellis et al., 1995; Xu et al., 1994; Patel et al., 
1996) and axonal guidance (Cheng et al., 1995; Drescher 
et al., 1995; Holash and Pasquale, 1995; Henkemeyer et al., 
1996). While the p85 subunit of phosphatidylinositol 3-kinase, 
(Src-like adapter protein) (SLAP), and the Src family ki- 
nase Fyn are the only known potential targets for Eph- 
related  kinases  (Pandey  et  al.,  1994; 1995; Ellis  et  al., 
1996), recently a number of related but distinct molecules 
have been  identified as the ligands for receptors  of the 
Eph subfamily (Bartley et al., 1994; Beckmann et al., 1994; 
Cheng and Flanagan, 1994; Davis et al., 1994; Shao et al., 
1994; Bennet et al., 1995; Bergemann et al., 1995; Bram- 
billa et al., 1995; Drescher et al., 1995). These ligands are 
unusual in that they are cell surface-associated proteins 
rather than soluble growth factors. Two of the ligands are 
transmembrane proteins (Beckmann et al., 1994; Shao et 
al.,  1994;  Bennett et al.,  1995;  Bergemann et al., 1995), 
while the others contain a consensus sequence for glycosyl 
phosphatidylinositol linkage. Each ligand interacts in vitro 
with more than one Eph-related receptor, but with varying 
affinities (Bartley et al., 1994; Cheng and Flanagan, 1994; 
Davis et al., 1994; Shao et al., 1994; Bergemann et al., 1995; 
Brambilla et al., 1995). 
The study of the regulation of the catalytic activation of 
receptor protein-tyrosine kinases in tissues is likely to pro- 
vide valuable insight into their in vivo functions. In the 
case  of several  receptor  protein-tyrosine kinases,  auto- 
phosphorylation correlates with increased enzymatic activ- 
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1991; van der Geer and Hunter, 1991; Longati et al., 1993; 
Soans et al., 1994)  and can be examined without knowl- 
edge of the activating ligand. Thus, the level of activation 
can be inferred from the level of autophosphorylation on 
tyrosine, which is presumably regulated by the availability 
of ligand. It is, therefore, important to examine not only 
the distribution of the kinase but also its level of tyrosine 
phosphorylation. The Eph-related receptor Cek5, for ex- 
ample, is highly expressed during retinal development in 
the chicken, and there is a dramatic increase in its level of 
tyrosine phosphorylation over a  few days during retinal 
differentiation, suggesting an important role for Cek5 in 
retinal histogenesis (Pasquale et al., 1994). 
Cek9 is a member of the Eph subfamily closely related 
to Cek5 (Sajjadi and Pasquale, 1993). Here we report the 
entire  Cek9  cDNA  sequence  and  the  identification of 
Cek9', a variant form of Cek9. We have used specific poly- 
clonal antibodies to characterize the expression pattern of 
Cek9  during embryonic development and  examined its 
level of catalytic activation in various embryonic tissues, as 
determined by its phosphorylation on tyrosine. Assessing 
the expression pattern of the activated protein is impor- 
tant to understand the physiological function of Cek9 and 
facilitate the identification of its ligand and substrates. 
Materials and Methods 
cDNA Library Screening 
Clones extending into the 5' region of the Cek9 cDNA were searched for 
by screening a  10-d chicken embryo kgt11  library (Clontech Labs, Palo 
Alto, CA) with a probe comprised of nucleotides 1309-1912 of Cek9 and 
corresponding to the 5' end of the Cek9 sequence previously published 
(Sajjadi  and  Pasquale,  1993).  The probe  was labeled  with digoxigenin 
dUTP (Boehringer Mannheim Corp., Indianapolis, IN) by random prim- 
ing and used for hybridization at high stringency as previously described 
(Pasquale, 1991; Sajjadi and Pasquale, 1993).  A  plaque identified as posi- 
tive (clone L13B) was subjected to several rounds of purification before 
purifying h phage DNA with gravity-flow columns (QIAGEN, Inc., Chats- 
worth, CA). The insert was subcloned into pBluescript and its sequence 
analyzed on both strands, using the dideoxynucleotide chain-termination 
technique with Sequenase (United States Biochem. Corp., Cleveland, OH). 
PCR Amplification 
1 Ixl intact phage (105-107 pfu) was used as template for PCR amplifica- 
tion of each eDNA library using the following program: one cycle for 1.5 
rain at 94°C, 1 min at 52°C, and 3 min at 72°C, followed by 34 cycles for 
1 min at 94°C, 2 min at 52°C, and 3 min at 72°C. The following eDNA li- 
braries were amplified by PCR:  10-d whole chicken embryo (Clontech 
Labs), 13-d chicken embryonic brain (gift of Dr. Barbara Ranscht, The 
Bumham Institute, La Jolla, CA), ll-d chicken embryonic retina (Novagen, 
Inc., Madison, WI), and adult chicken brain library (Clontech Labs). The 
region containing the initial ATG was amplified using the oligonucleotide 
GGTGGAGTCTACAGAGAATCT (corresponding to nucleotides 116- 
136)  as the sense primer and CTGACCTGGTTCATCCATGTT (corre- 
sponding to nucleotides 378-358) as the antisense primer. The juxtamem- 
brane region was amplified using the oligonucleotide ATGGCACAG- 
GACCGACTGCC (corresponding to nucleotides 1792-1811) as the sense 
primer and  ATCAATGTAATACTTCACTC (corresponding to  nude- 
otides 1974-1955) as the antisense primer. The PCR products were sepa- 
rated on 1.5% agarose gels and photographed. In some cases, amplified 
fragments were gel purified, ligated into the pCRII cloning vector (InVi- 
trogen, San Diego, CA), and sequenced. 
Antibodies 
Anti-Cek9 antibodies were prepared using two different antigens: (I) a pep- 
tide corresponding to the carboxy terminus of Cek9 and (2) a histidine- 
tagged Cek9 fragment corresponding to the 101 carboxy-terminal amino 
acids. To prepare the first antibody, the peptide KVHLNQLEPVEV, cor- 
responding to the 12 carboxy-terminal amino acids of Cek9, was coupled 
to BSA using glutaraldehyde (Harlow  and Lane, 1988)  and injected in 
rabbits to raise immune serum. The antipeptide antibodies were affinity 
purified on a column in which the peptide antigen was coupled to N-hydroxy- 
succinimide-activated agarose (Affi-Gel 10, BioRad Labs, Hercules, CA). 
To prepare the second antibody, the cDNA coding for the COOH-termi- 
hal 101 amino acids of Cek9 was amplified by PCR using the oligonucle- 
otides GCAAGCCATCTGCTCTCAAA (corresponding to  nucleotides 
2834-2853) as the sense primer and GAGTCTGGTGAAATAGAGAC 
(corresponding to nucleotides 3169-3150) as the antisense primer. A plas- 
mid containing the appropriate region of the Cek9 cDNA was used as the 
template. The  amplified segment was gel purified  and cloned into  the 
pCRII cloning vector (InVitrogen). Several of the resulting plasmids were 
sequenced to confirm that no mutations were introduced. One plasmid 
was digested in the polylinker region with the restriction enzymes BamHl 
and PstI to release the amplified fragment. The BamHI-PstI fragment was 
then cloned into the expression vector pQE31 (Qiagen, Inc.) to overex- 
press the Cek9 COOH-terminal fragment as a histidine-tagged fusion pro- 
tein in M15 (pREP4)  cells (Qiagen, Inc.). After induction, the bacteria 
were resnspended in 8 M urea, 0.1 M NaPi, and 0.01 M Tris, pH 8.0, and 
lysed by sonication. The lysate was centrifuged at 15,000 g for 20 min and 
the supernatant, containing the histidine-tagged Cek9 fragment, was run 
through a  Ni-NTA column (Qiagen, Inc.). After washing with the same 
urea buffer at  pH 6.3,  the Cek9 polypeptide  was eluted with  the urea 
buffer at pH 4.5. After dialysis against PBS, the purified Cek9 polypeptide 
was used to inject rabbits to raise immune serum. 
The antibodies to the histidine-tagged Cek9 carboxy terminus were af- 
finity-purified using two different columns. One column was prepared by 
coupling the histidine-tagged Cek9 fragment, purified by SDS-PAGE, and 
eluted from the acrylamide to Affi-Gel 15. The second column was pre- 
pared  by coupling to  Affi-Gel  10  a  glutathione-S-transferase (GST) L 
Cek9 fusion protein purified with glutathione-agarose beads according to 
the manufacturer's recommendations (Pharmacia, LKB Biotechnology, 
Piscataway, N J). To produce the GST-Cek9 carboxy terminus fusion pro- 
tein in the XL1 Blue strain of Escherichia coli, the cDNA coding for the 
carboxy terminus of Cek9 was excised from the pQE31 vector by diges- 
tion at two EcoRl sites flanking it and cloned into the vector pGEX-1 
(Pharmacia LKB Biotechnology). Each antibody was further purified by 
incubation with the insoluble material obtained after sonication of bacte- 
ria  expressing a  13-galactosidase-Cek5 fusion protein  (Pasquale,  1991). 
This removes antibodies that may be present recognizing Cek5 or bacte- 
rial proteins. Anti-Cek9 carboxy-terminal peptide antibodies were used 
for the whole-mount immunoloealization experiments (see Figs. 4 and 5). 
The anti-Cek9 antibodies purified with the histidine-tagged Cek9 carboxy 
terminus were used in the immunoprecipitation experiments and for the 
immunoblotting experiments in Fig. 10 B (except for cerebrum and thigh 
muscle) and Fig. 11. The antibodies purified with the GST-Cek9 carboxy 
terminus were used for the remaining immunoblotting experiments and 
for immunohistochemistry,  except for the whole-mount experiments. The 
different antibody preparations were compared in immunoblotting exper- 
iments and they produced similar results. However, when used to probe 
whole tissue extracts, the antipeptide antibodies produced a weak signal 
and the antibodies purified on the histidine-tagged antigen produced  a 
higher background than those purified on the GST-Cek9 fusion protein. 
The preparation of antiphosphotyrosine, anti-Cek4, and anti-Cek8 anti- 
bodies have been described previously (Soans et al., 1994). Anti-Cek5 an- 
tibodies were prepared using the peptide QMNQIQSVEV, which corre- 
sponds to  the  10  carboxy-terminal amino acids,  coupled  to  BSA  with 
glutaraldebyde (Harlow and Lane, 1988),  and purified on an affinity col- 
umn containing a GST-Cek5 carboxy terminus fusion protein comprising 
amino acids 897-995 of Cek5. Anti-GST antibodies were obtained from 
immune serum raised to the GST-Cek5 carboxy terminus fusion protein 
and affinity-purified using bacterially expressed GST coupled to N-hydroxy- 
sueeinimide-activated agarose (Affi-Gel 10). 
Immunoblotting 
Bacteria, dissected tissues, or whole chicken embryos were sonicated in 
PBS containing 1 mM phenylmethylsulfonyl  fluoride, 0.2 trypsin inhibitor 
1. Abbreviation used in this paper: GST, glutathione-S-transferase. 
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sodium orthovanadate. The samples were stored in aliquots at  -70°C. 
Equal amounts of protein were loaded in each lane after boiling the ly- 
sates for 3 min in sample buffer containing SDS. The tissue extracts or 
bacterial lysates were resolved by SDS-PAGE and transferred onto nitro- 
cellulose. The nitrocellulose filters were stained with amido black to con- 
firm that equal amounts of protein were present in each lane, blocked 
overnight in 3% BSA in TBS and incubated for 4 h in 3% BSA in TBS 
containing 0.1  ttg/ml anti-Cek9 antibody (see Fig. 2), 3 Ixg/ml anti-Cek9 
antibody, 3 I~g/ml anti-phosphotyrosine antibody, or 0.8 p.g/ml  anti-GST 
antibodies.  The  immunoblots were incubated with 0.2 ~g/ml protein 
A-peroxidase (Sigma Chemical Co., St. Louis, MO) in 3% BSA in TBS for 
1 h, rinsed several times with TBS, and developed using enhanced chemi- 
luminescence reagents (Amersham Corp.,  Arlington Heights, IL).  The 
membranes were reprobed with different antibodies after drying for a 
few hours, followed by incubation in blocking solution containing 0.2% 
sodium azide to inhibit the peroxidase activity remaining on the filters. 
Immunoprecipitation 
Tissue extracts were diluted in RIPA buffer (150 mM sodium chloride, 10 
mM sodium phosphate, pH 7.2, 1% deoxycholate, 1% Triton X-100, 0.1% 
SDS)  and 0.1  mM sodium orthovanadate and precleared with Staph A. 
Whenever antiphosphotyrosine antibodies were to be used for immuno- 
blotting  of the immunoprecipitates, phosphotyrosine was added  to  the 
sonicated extract to a final concentration of 8 mM. The samples were then 
incubated for 40 min with 5  to 10 ~.g of antibodies that had previously 
been absorbed to 5-10 ill Staph A. The immunoprecipitated material was 
washed three times with RIPA buffer and once with PBS. Sample buffer 
was added and the immunoprecipitates were boiled for 5 min, separated 
on 7.5% polyacrylamide gels, and then transferred onto nitrocellulose for 
immunoblotting. Tissue extracts were used in excess, so that the amounts 
of immunoprecipitated receptors would not be dependent upon their ex- 
pression levels. 
To determine the fraction of tyrosine-phosphorylated Cek9, 50 p.g of 
anti-Cek9 antibody was used to immunoprecipitate Cek9 from a 10-d em- 
bryonic  retina  extract.  The  immunoprecipitate,  which  contained  both 
phosphorylated and nonphosphorylated Cek9, was boiled in 0.1  ml 1% 
SDS for 5 min, centrifuged for 3 min to remove the insoluble Staph A, and 
the supernatant was transferred to a fresh tube containing 0.9 ml of RIPA 
buffer lacking SDS. This was added to 50 p,g of antiphosphotyrosine anti- 
body preabsorbed to Staph A to immunoprecipitate the tyrosine phosphor- 
ylated fraction of Cek9. The sample was incubated on ice for 40 min with 
occasional vortexing and  then centrifuged for 3  min. The supernatant, 
containing nonphosphorylated Cek9, was transferred to a  different tube 
containing 50 ~g of anti-Cek9 antibodies preabsorbed to Staph A  and 
subjected  to  immunoprecipitation. The  immunoprecipitates were  then 
probed with antiphosphotyrosine antibodies or anti-Cek9 antibodies after 
separation on a 7.5% polyacrylamide gel. 
Immunohistochemistry 
Embryos were removed from the eggs, fixed in 4% paraformaldehyde and 
0.1 mM sodium orthovanadate in PBS for 16 to 24 h, and then cryopro- 
tected in 20%  sucrose in PBS and 0.1  mM sodium orthovanadate.  Em- 
bryos were then embedded in OCT compound (Miles Inc., West Haven, 
CT) and frozen in dry ice/2-methylbutane. Cryostat sections, 10-gm thick, 
were collected on polylysine-coated glass slides and stored at -70°C. The 
sections were treated with 0.3%  H202 for about 10 min, followed by a 
blocking buffer containing 1.5% normal goat serum in PBS for 30 min. 
Sections were incubated in rabbit anti-Cek5 or anti-Cek9 antibodies (5-10 
p~g/ml) in 3%  BSA for 30 min. After incubation with the primary anti- 
body, the sections were rinsed several times with PBS and incubated with 
biotinylated goat anti-rabbit  antibody  (Vector  Labs, Inc.,  Burlingame, 
CA) for 30 min. Antibody binding was visualized using the Vectastain 
ABC elite avidin-biotin-horseradish peroxidase technique (Vector Labs). 
After reacting in diaminobenzidine for ~2-3 min, the sections were rinsed 
in PBS, air dried, mounted in Permount, and sealed with a No. 1 coverslip. 
Controls involved preincubation of the affinity-purified antibodies with 
the antigen before use. Specimens were photographed with an inverted 
microscope (model 405M; Carl Zeiss, Inc., Thornwood, NY). 
Whole-mount immunohistochemistry was performed as described by 
Henkemeyer et al. (1994), with the following minor modifications: The 
concentration of Triton X-100 used throughout was 0.1%. The embryos 
were bleached in methanol-DMSO-30% H202 (4:1:1).  Anti-Cek9 peptide 
antibodies were used at a concentration of i  p.g/ml. The specificity of the 
anti-Cek9 antibody staining was confirmed by incubating the antibodies 
with the peptide antigen (50 p~g/ml) for 30 min before addition to the em- 
bryos. As a further control, preimmune serum was used at a dilution of 1: 
10,000  to  obtain a  concentration of antibodies of ~1  ixg/ml.  Antibody 
binding  was  visualized  using the  Vectastain  ABC  elite  avidin-biotin- 
horseradish peroxidase technique (Vector Labs, Inc.). Embryos were in- 
cubated in diaminobenzidine for 20 min and then with diaminobenzidine, 
H202 and NiCI2. Usually 2-3 min proved sufficient for color development. 
After staining, the embryos were washed in PBT (PBS containing 0.2% 
BSA, 0.1% Triton X-100), followed by PBS, and photographed in PBS. 
Alternatively, after washing in PBT, the embryos were dehydrated in a 
methanol/PBS series, cleared  in (benzyl alcohol-benzyl benzoate  [1:2])- 
methanol (1:1)  for 20 min and photographed in (benzyl alcohol-benzyl 
benzoate [1:2]). Kodak Gold 100 print film (Kodak Co., Rochester, NY) 
was used for photography with a  stereomicroscope (model Stemi SV11; 
Carl Zeiss, Inc.). 
In Situ Hybridization 
Embryos were fixed in 4% paraformaldehyde and embedded in paraffin. 
5-~m sections were cut with a microtome and mounted on slides (model 
Superfrost Plus; Fisher Scientific, Pittsburgh, PA).  In situ hybridization 
was performed according to standard procedures (Simmons et al., 1989). 
Briefly, deparaffinized  sections were  deproteinated  in 0.2  M  HC1  and 
treated with 2.5 ixg/ml proteinase K. After acetylation and dehydration in 
ethanol, the sections were  air  dried.  The sections were  then incubated 
overnight with the Cek9 a3p-labeled rihoprobes (about t04 dpm/p~l) in hy- 
bridization buffer (300 mM NaCI, 20 mM Tris, pH 8.0, 5 mM EDTA, 1× 
Denhardt's, 0.2% SDS, 10 mM DTT, 0.25 mg/ml tRNA, 50% formamide, 
10%  dextran sulfate) at  50°C.  After hybridization, the slides were  im- 
mersed in 4× SSC (150 mM NaCI, 15 mM Na  3 citrate.2H20), followed by 
two  15-min washes in 2×  SSC at 63°C, RNaseA digestion, one 30-min 
wash in 0.1x SSC at 63°C, and one 10-min wash at room temperature. Af- 
ter dehydration, the sections were air dried, exposed to x-ray film for 2 d, 
and then dipped in photographic emulsion and exposed for 2 wk before 
development. The developed slides were then counterstained with cresyl 
violet and photographed. 
The sense and antisense riboprobes  were prepared  by using a  Cek9 
fragment (nucleotides 490-710), amplified by using the polymerase chain 
reaction, and cloned in the pCRII vector (InVitrogen) as a template. Af- 
ter linearization of the plasmids with BamHI, the riboprobes were synthe- 
sized with T7 RNA polymerase using a Promega in vitro transcription sys- 
tem (Madison, WI) and [33p]UTP,  according to the specifications of the 
manufacturer for the preparation of high specific activity riboprobes, with 
some modifications. The modifications were as follows: the reaction vol- 
ume was reduced from 20 to 11.5 i~1, and spin columns (model CHROMA 
SPIN-10;  Clontech  Labs)  were  used to  remove  unincorporated  nucle- 
otides. 
Results 
Cek9 and Cek9' 
A  partial  Cek9  cDNA  clone  (comprised  of nucleotides 
1309-3712 in Fig. 1 A) was previously isolated by screen- 
ing a 10-d chicken embryonic cDNA library using a Cek5 
cDNA probe (Sajjadi and Pasquale, 1993). However, this 
clone encodes only a small portion of the Cek9 extracellu- 
lar  domain.  By screening the  same  10-d whole  embryo 
cDNA library with a 0.6-kb probe corresponding to the 5' 
end  of the  Cek9  cDNA  previously isolated,  a  2342-bp 
clone (L13B), corresponding to  Cek9'  in Fig.  1 A,  was 
identified.  Clone  L13B  encodes  the  entire  extracellular 
and transmembrane domains of Cek9 and a portion of the 
cytoplasmic domain. However, the ATG predicted to en- 
code the initial methionine is not followed by a typical hy- 
drophobic signal peptide sequence and corresponds to the 
region immediately following the signal peptide of other 
Eph-related receptors. Hence, clone L13B appears to en- 
code  a  form  of Cek9  lacking  a  signal  peptide.  To  test 
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Cek  9 ' 
C  G~-'TCT  ~KCT'PI'GTGTTAAC  ~T~'A  T  ~  ~  CT  ~  CATT  ~  ~~A  T  ~ 
A~TCT~TCTTCAT  GGATI'CTAAT  ~'~&~'I~A~&%A~T~TCAGGAAT  GGA~~T~k~A~±~.~"TTCTTTCATCTA~I,C.ACTT~ 
MT  Z  Z  L  L  D  T  T  G  F.  T  S  se  I  GWT  9  H  p  p  D  a 
c~aacc.aacc~aaa~aa~,~,~aT  c~a~c~m~  ~ac~zcm~cmcmcaccc~ 
w  ~  •  v  s  v  1%  ~  ~  ~  •  1%  ~  x  ~  m  •  ~  v  c  ~  ~  D  ~  ~  a  ~  ~  ~  w  ~.  a  ~  .  r ............... 
Cek  9 
~GGTTTATC~ACTGGTTC~  56 
M  D  S  N  A  D  T  ~  A  R  R  V  S  13 
CAAAACACTC~CTCTGAACCATT~~TGTGTGTTTATTGGATAT  ~CTACAGAGAATCTTCATGGATTCTAAT  ~CAGT~GTC  176 
G  M  D  W  L  W  T.  V  C  F  F  H  L  V  T  S  L  E  $E  I  L  L  D  T  T  G  R  T  S  R  I  G  W  T  S  M  P  P  D  G  53 
AGGA~  T  ~CTGGCTGGTTTGCTT=  •  •  •  CATCTAGTCACTT CJ~%~%~TT~TGGATACAACTGGAGAAACCTCAGAGATTGGCTGGACCTCTCACCCTCCTGATGG  296 
W  E  E  V  S  V  R  D  D  K  B  R  Q  I  R  T  r  Q  v  c  N  M  D  E  P  G  Q  N  N  W  L  R  T  H  F  I  E  R  K  G  93 
GTGGGAAGAAGTAAGTGTCCGGGATGATAAGGAGCG~CAGATC  CGAAC  CTTTCAAGTTTGTAACATGGATGAAEC~-GGTCAGAATAACTGGTTG~~  416 
A  H  R  V  H  V  R  T.  H  F  S  V  R  D  C  A  S  M  1%  T  V  A  8  T  C  K  R  T  F  T  T.  y  y  H  Q  8  D  V  D  I  133 
AGC  C  C-AC  C  g~.GP~  C  CA-T  ~  C  ~  C  ~  ~  C~JGT  ~GGGL~.CT  G'J~  ~  ~  ~LC~J~  ~  GkIC  CT  ~  ~.~C..~  ~C~=.~C~-.~J~  ~  C.~G~E  ~  ~  536 
A  S  Q  E  L  P  E  W  H  E  G  P  W  T  K  V  D  T  I  A  A  D  E  S  F  S  Q  V  D  R  T  G  K  V  V  llt  M  N  V  K  173 
~  L"T  C~  ~CJ~  G~.~  ~  CC  T~J~TATTGCAGCT  GAT  GAAA~CTTTTC C  CA~GT  ~  ~  656 
V  i%  S  F  G  P  T.  T  K  H  G  F  Y  L  A  •  Q  D  8  G  A  C  M  S  L  V  A  V  Q  V  •  •  Y  K  C  P  A  V  V  K  213 
A~TAC~cAC-CTTT~CA~T~T~]~TT~A~CTGGCCTT~CA~GA~Tc~GA~CCT~CT~~A`~"x~"A~c~  776 
G  F  A  S  •  P  E  T  •  A  G  G  E  R  T  S  L  V  E  S  L  G  T  C  V  A  N  A  E  R  A  S  T  T  G  S  9  G  V  R  253 
AGGATTTGCCTCCTTCCCTGAAACTTTTGCTGGAGGAGAGAGGAC~GGTGGAGTCACTAGGGACGTGTGT~  GGGTCATCAGGTGTTCG  896 
L  H  C  N  G  E  G  E  W  M  V  A  T  G  R  C  S  C  K  A  G  Y  Q  S  V  D  N  Z  Q  A  C  Q  A  C  P  I  G  S  •  K  293 
GTTGC.ACT~GGATGGTGGCCACTGGACGATGCT~GGTTACCAATCTGTTQA~  CC~-rr~-AA  1016 
A  S  V  G  D  D  P  C  L  ~-  C  P  A  H  S  H  A  P  I'  P  G  S  I  E  C  V  C  Q  S  H  Y  Y  1%  $  A  S  D  N  S  D  333 
AGCATCTGTGGGAGATGACCCTT~CCTTCTCTGC  CCTGCCCACAGCCATGCTCCACTGCCAGGTTCCATTGAAT~~~~~  1136 
A  P  C  T  G  i  P  8  A  P  R  D  L  S  Y  E  I  V  G  S  N  V  L  ~.  T  W  1%  L  P  K  D  ~.  G  G  1%  K  D  V  •  •  373 
TGCTCCC~GG~ATCCCCTCTGCTCC  CCGT  GACCTCAGTTATGAAATT GTTGGCTCCAACGTGCTCCTGACCTGGCGCCTC  CC~~C~~  ~  1256 
N  V  I  C  K  E  C  P  T  R  3  A  G  T  C  V  1%  C  G  D  N  V  Q  •  E  P  1%  O  V  G  L  T  B  S  1%  V  Q  V  S  N  413 
CAATGTCATCTGCAAGGAATGCCCAACAA~GTCAGCAGGGACATGTGTG~2~CT  GTGGGGACAATG~ACA~-~  ~~~~~  1376 
L  L  A  1%  V  Q  Y  T  F  E  I  Q  A  V  N  L  V  T  R  L  S  S  R  A  P  Q  Y  A  T  I  N  V  S  T  S  Q  $  V  P  9  453 
CCTATTGGCCCGTGTC-CAGTACA~ ~  ~  ~"-'~-A'~GATC~GTCAATTTGGTGACTG~  .GCACCCCAGTATG~TAC~CAGTCAGTGCCCTC  1496 
A  I  P  M  M  K  Q  V  S  R  A  T  S  S  I  T  L  S  W  P  Q  P  D  Q  P  N  G  V  I  D  D  Y  Q  L  R  Y  •  D  K  A  493 
CGCa~ATCCCTATGATGCATCAGGTGAGTCGTGCTAC~TCACACTGTCTTGG~CTCAGC~C~~~~~  x  ~'-  -&  ~  1616 
Z  D  E  D  N  8  F  T  L  T  S  m  T  N  M  A  T  I  L  N  L  S  P  G  K  I  Y  V  •  ~  V  R  A  I%  T  A  V  G  Y  G  533 
AGAAGATGAGGATAATTCATTTACTTTGACTAGTGAAACTAACAT  GGCCACTAT  CCAGGCAAGA~CTTCCAAGTAC~GG  1736 
P  Y  3  G  K  M  ¥  •  Q  T  L  M  A  G  E  H  S  E  M  A  Q  D  R  L  P  L  I  V  G  3  A  L  G  G  L  A  •  L  V  X  573 
C  C  ~F..R~IR~G~AG~kTGT~eET  C  ~  ~kT~ATG~CAF.A~%C C~CT  ~  ~  ~  C'I~9~C~_mT  CTT(R~TA~%~  1856 
A  A  I  A  I  L  A  I  T  •  K  S  K  1%  P.  !  T  P  Y  T  D  1%  L  Q  Q  Y  ~  S  T  R  G  ~  G  V  K  Y  Y  I  D  P  613 
TGCTGCCATTGCCATTCTTG~CJLTCATCTTCAAGAGT~AAAGGCGAGAGACT  CCAT~GK:  ~~GAGG~  ACATTGATCC  1976 
o  o  o 
S  T  Y  E  D  P  N  E  A  I  1%  E  F  A  K  E  I  D  V  S  •  I  K  I  E  E  V  I  G  S  G  E  F  G  E  V  C  •  G  1%  653 
TTCCACGTATGAAGATCCCAATGAAGCTATTCGAGAGTTTG~2  CAAAGAGATAGATGTGTCCTTCATCAAAATTGAGGAGGT~~~~G  2096 
o 
L  K  H  P  G  K  R  l  Y  T  V  A  I  K  T  L  K  S  G  ¥  T  D  B  Q  R  1%  E  F  L  S  E  A  S  I  M  G  Q  •  E  H  693 
CCTAAAACACCCAGGGAAACGTGAATACACAGTAGCTATTAAAACCC~~  GATGAACAGCGTCGAG~J3TTCCTG~,~2~~~  2216 
P  N  V  I  H  L  E  G  V  V  T  K  S  R  P  V  M  I  V  T  E  •  M  E  N  G  S  L  D  S  •  L  1%  Q  K  E  G  Q  •  3  ?33 
TCCCAATGTCATCCACCTGGAGGGC  GTGGTCACCAAAAGCCGACCAGTCATGATTGTCACAGAATTCATGGAGAATGGAT  CACT~C~C~~~  2336 
V  I~  Q  L  V  G  M  L  1%  G  i  A  A  G  M  I%  Y  L  S  D  M  N  Y  V  H  1%  D  L  A  A  31.  I~  I  L  V  N  8  N  L  V  ??3 
T~G~AC~%~CT~G~TG~TACGAGGGATTGCAGCAGGcATGCGcTACCTTTCAGAcATGAAcTATGTGCATCGTGATcT~GCAGcACGTAA~AT~~  2456 
C  K  V  S  D  •  G  L  S  1%  •  L  E  D  D  A  S  N  ¥  T  ~  T  G  A  L  G  C  K  I  P  I  1%  W  T  A  P  E  A  V  Q  813 
ATGCAAGGTGTCAGACT  TTG~-A  ~-~A~GTCTCGCTTTCTGGAA~ATGATGCTTCAAAT~CACTTATACTGGAGCTCTGG~TTGC-~AAAT~CATCCGTTGGAcT~c~C~  2576 
Y  R  K  •  T  S  S  8  D  V  W  S  Y  G  I  V  M  W  R  V  M  S  Y  G  R  R  P  Y  W  D  M  8  N  ~  D  V  X  N  A  I  853 
GTATCGCAAGTTCACCTCCTC  CAGTGATGTCTGGAGCTATGGCATTGTCAT  ~GATGTCCTATGGTGAGAGACCTT~TGTCC.AAC~TTAAT~  2696 
D  Q  D  Y  R  ~.  P  P  P  P  D  C  P  T  V  L  H  L  L  M  L  D  C  W  Q  K  D  I%  V  Q  R  P  K  •  i  Q  I  V  8  A  893 
T  GACCAGGAET~TCGCCTGCCACCACCCCCAGACTGC  CCAACT~-~'~ GCATCTGCTGRTGCTTGACT~GGCAGAA~C~~~~  2818 
L  D  K  M  I  R  K  P  S  A  L  K  A  T  G  T  G  S  S  1%  P  S  Q  P  L  I'  S  N  8  P  P  D  1'  P  S  L  S  N  A  H  933 
~cTAGATAAAATGAT~GcAAGcCATCTGcTcTCAAAGc~GGGA~cAGCAGAccATcTCAGccTcT~CTGAGcAA~C~cTcCAGA~  CTTCACTCAGCAATGCCCA  2936 
E  W  L  D  A  I  K  M  G  R  Y  K  I  N  F  D  Q  A  G  L  I  T  •  D  V  I  S  1%  M  T  L  •  D  L  Q  R  I  Q  I  T  9?3 
CGAGT  GGTTGGATGCCATCAAGATGGGTCGTTACAAGGAGAAx  ~-~'~GGTCTGATTACATTTGATGTCATAT~T~~C~~T~  3056 
L  V  G  H  Q  K  K  I  L  I;  S  Z  ~  L  M  K  V  H  Z,  N  Q  ~  ~  ¥  V  E  V  *  1000 
CCTGGTTG~TCACCAGAAAAAGATTCTAAACAGCATCCAGCTCAT~k~J~t  ~*~*~C~CCAGCTTGAACCAGTTGAAGTGTGATGCTTTAAGT~~~  317 
GAAAGAGTCCT ~TT~J~TGTCACTGTAT~GAAGACTTACTGCAC  TT~CCJLTTCCAC~  3296 
AAGAGAATCTTGCCATC~  GGT~  3616 
ATAATAGTTTGGACAGAC~CTGCT~CCACTAAAT  A~A~%AT~Ut  ~J~~CAT~~CACAATT  3536 
TTTCCAAGAGAGT  GAGAGTTATCACTCA~TTGGRAATGGACAT~ATGCCAGATTT~fGAGAAACTGGAGTTCCACTGAGTGCAC~A~ACAA  3656 
T.~AG~,~.~_Z%T  CAC  C,I.CGT.,~:  ~.-A-A-A~.AGAGG~  ~KGGGC  C  C~  3 '7 0 6 
The Journal of Cell Biology, Volume 135, 1996  784 Figure 1.  Molecular characterization of the Cek9 and Cek9' cDNAs. (A) Nucleotide sequence and predicted amino acid sequence of 
the Cek9' and Cek9 receptor tyrosine kinase cDNAs (GenBank Accession No. U23783). The amino acids comprising the presumed sig- 
nal peptide sequence and the putative transmembrane domain are underlined. Potential sites for N-linked glycosylation are marked by 
dotted overlines. Nucleotides marked by a double underline represent the insert present in the Cek9' cDNA, but not the Cek9 cDNA. 
An arrow marks the position of the insertion in the Cek9 sequence. Only the 5' end of the Cek9' sequence is shown, since the remaining 
portion (indicated by dots) is identical to the corresponding region of Cek9. Some amino acid residues within the kinase domain that are 
involved in ATP binding are labeled by open circles, and tyrosine 796, corresponding to a conserved site of autophosphorylation, is indi- 
cated by a filled circle. The sequences are in bold characters, except for the ATG codons in the 5' untranslated regions and a potential 
polyadenylation signal (AATAAA) in the 3' untranslated region. The nucleotides are numbered starting from the first residue follow- 
ing the EcoRI site of hgtll. The numbering refers to the Cek9 amino acid and nucleotide sequence. (B) PCR amplification of chicken 
cDNA libraries.  Ethidium bromide staining of a 1% agarose gel reveals two bands corresponding to the two variant forms Cek9 and 
Cek9'. The larger bands result from the amplification of Cek9', which contains an insert.  Lane 1, 1 kb DNA ladder (GIBCO BRL); lane 
2, amplification of Cek9' cDNA subcloned in pBluescript; lane 3, amplification of an adult chicken brain cDNA library; lane 4, amplifi- 
cation of a 10-d chicken embryo cDNA library; and lane 5, amplification of an 11-d embryonic chicken retina cDNA library. The posi- 
tions of the primers used are indicated in (C). The positions of several DNA size markers are indicated at left. (C) Schematic represen- 
tation of the domain structure of Cek9 and Cek9'. SP, signal peptide; cys, cysteine rich region; III, fibronectin type III repeats; TM, 
transmembrane domain; and K, kinase domain. Untranslated regions are indicated by a line, the 64-bp insertion in Cek9' is indicated by 
a dotted line. Arrows indicate the positions of the primers used for the PCR amplifications shown in (B). 
whether  this  represents  a  possible  variant  form of Cek9, 
we used primers upstream and downstream of the putative 
initial ATG for PCR amplification using chicken cDNA li- 
braries  as  templates.  Two bands  were  obtained  with  the 
10-d whole embryo library and an adult chicken brain li- 
brary, while only the lower band was detected after ampli- 
fication of an 11-d embryonic retina library (Fig. 1 B). By 
Southern analysis, both bands hybridized with a  digoxige- 
nin labeled probe prepared by amplification of clone L13B 
with the same primers (not shown). The two products ob- 
tained  from  amplification  of the  10-d  whole  embryo  li- 
brary  were  subcloned  and  sequenced.  The  upper  band 
(326 bp) corresponds to a fragment of clone L13B, as ex- 
pected based on its size, and contains an insertion of 64 bp 
that is not present  in the lower band (262 bp). In the ab- 
sence of the 64-bp insertion,  the  open reading frame ex- 
tends further to the 5' end and an upstream ATG is pre- 
dicted to represent the site for translation initiation (Cek9 
in Fig. 1 A). The initial methionine is followed by a hydro- 
phobic sequence that is likely to represent a signal peptide. 
The sequences of Cek9 and Cek9' are shown in Fig. 1 A, 
and the structure of the two isoforms is schematically rep- 
resented in Fig. 1 C. 
To  search  for  additional  isoforms  of  Cek9,  several 
chicken cDNA libraries  were used  as templates  for PCR 
amplification  of the  Cek9 juxtamembrane  domain,  since 
variant forms of several other Eph-related  kinases  have 
insertions in the juxtamembrane domain (Sajjadi and Pas- 
quale, 1993; Maisonpierre  et al., 1993; Siever and Verder- 
ame,  1994; Connor and Pasquale,  1995). The libraries  in- 
cluded  the  10-d  whole  embryo  library,  ll-d  embryonic 
retina library and adult brain library described above, and 
a 13-d embryonic brain library, cDNA prepared by reverse 
transcription PCR from 8-d retina mRNA was also used as 
template. These experiments did not provide evidence for 
the existence of isoforms of Cek9 containing inserts in the 
juxtamembrane domain (not shown). 
Expression of Cek9 during Embryonic Development 
The  carboxy  terminus  of  the  Eph  receptors  comprises 
about 100 amino acids and is one of the least conserved re- 
gions (Sajjadi and Pasquale, 1993; Fox et al., 1995). In par- 
ticular, the 10--12 amino acids at the extreme carboxy ter- 
minus exhibit very little  conservation. As a  consequence, 
the carboxy terminus has been the region targeted for the 
preparation of antibodies specific for a number of Eph re- 
ceptors (Lindberg and Hunter,  1990; Lhot~ik et  al.,  1991; 
Henkemeyer et  al.,  1994; Soans et  al.,  1994; Zhou et  al., 
1994;  Holash  and  Pasquale,  1995).  Three  different  anti- 
bodies  recognizing the  carboxy-terminal  region  of Cek9 
were  prepared  to  study  the  expression  pattern  of Cek9 
during embryonic development. One of the antibodies was 
prepared by using a synthetic peptide corresponding to the 
Soans et al. The Eph-related  Receptor Cek9 in Development  785 12 carboxy-terminal amino acids of Cek9 both as the anti- 
gen and for affinity-purification. A  second antibody was 
prepared by using both as the antigen and for affinity-puri- 
fication a  fusion protein containing the carboxy-terminal 
101 amino acids of Cek9 tagged with six histidine residues. 
A  third antibody was prepared using the same histidine- 
tagged fusion protein as the antigen, and a GST-Cek9 fu- 
sion protein comprising the carboxy-terminal 101  amino 
acids of Cek9 for affinity purification. After affinity purifi- 
cation, both antifusion protein antibodies were absorbed 
to a bacterial extract containing a 13-galactoside-Cek5 fu- 
sion protein (Pasquale, 1991). This was to remove antibod- 
ies  cross-reactive  with  sequences  conserved  within  the 
Eph subfamily that may have been present. In fact, the re- 
gions in the Cek9 carboxy terminus that are homologous 
to Cek5 are the same that are homologous to other Eph 
receptors, except that  the  amino acid conservation with 
Cek5 is more extensive than that with other more distantly 
related receptors (Sajjadi and Pasquale, 1993).  The speci- 
ficity of the  antibodies was  then  assessed by comparing 
their reactivity with  Cek9,  Cek5,  and  Cek8 (Fig.  2).  All 
three anti-Cek9  antibody preparations  preferentially de- 
tect the GST-Cek9 carboxy terminus fusion protein rather 
than GST fusion proteins containing similar carboxy-ter- 
minal  regions  of  the  closely related  kinases  Cek5  and 
Cek8. Because the anti-Cek9 antibodies do not recognize 
regions of Cek5 and Cek8 that share sequence homology 
with Cek9, they are unlikely to recognize the same con- 
served regions in other more distantly related receptors. In 
tissue extracts, all three anti-Cek9 antibodies recognize a 
120-kD  protein  that  undergoes  autophosphorylation  on 
tyrosine in vitro and after SDS-PAGE exhibits an appar- 
ent molecular weight lower than that of Cek5 (not shown). 
Because other Eph receptors exhibit interesting distri- 
bution patterns during the early stages of embryonic devel- 
Figure  2.  Specificity  of  the 
anti-Cek9  antibodies.  Puri- 
fied  GST  fusion  proteins 
containing similar portions of 
the carboxy termini  of Cek9 
(9), Cek8 (8), and Cek5 (5), 
as well as GST, were spotted 
on nitrocellulose filters in the 
amounts  indicated  at  left. 
They were probed with anti- 
bodies to: (A) GST; (B) the 
histidine-tagged  Cek9  car- 
boxy-terminal  101 amino ac- 
ids, purified  using the same 
histidine-tagged  fragment  of 
Cek9;  (C)  the  histidine- 
tagged  Cek9  carboxy-termi- 
nal 101 amino acids, purified 
using the  same  fragment  of 
Cek9  as  a  GST fusion  pro- 
tein;  and (D) the Cek9 car- 
boxy-terminal  peptide  (see 
Materials  and Methods  sec- 
tion). 
opment (Becker et al.,  1994; Ganju et al., 1994; Ruiz et al., 
1994; Henkemeyer et al.,  1994; Ellis et al.,  1995; Xu et al., 
1995; Patel et al., 1996), whole chicken embryo extracts at 
days 1.5 to 3.0 of development in ovo were examined by 
immunoblotting with anti-Cek9 antibodies to examine Cek9 
expression.  Cek9 can be detected by immunoblotting as 
early as embryonic day 1.5 and its level of expression in- 
creases with time of development (Fig. 3). The spatial dis- 
tribution  of Cek9  at  about  2  d  of development  (Ham- 
burger  and  Hamilton  stages  13-15)  was  examined  by 
whole-mount immunohistochemistry (Figs. 4 and 5). Cek9 
expression is most prominent in the eye, the brain and the 
posterior portion of the neural tube (Fig. 4). Cek9 immu- 
noreactivity above control levels is  also  apparent  in  the 
somites, with higher levels in the posterior (more recently 
formed) somites, but not in the condensing somites. Com- 
parison of the expression pattern of Cek9 in the posterior 
region of the 2-d embryo with that of Cek8 and Cek5 (Fig. 5) 
reveals marked differences. In the neural tube and somites, 
Cek8 immunoreactivity is concentrated in more posterior 
regions  than  Cek9  immunoreactivity (Fig.  5, A  and  B). 
Cek8 is highly expressed in the primitive streak, the four 
or five most recently formed somites, and the condensing 
somites.  In  addition,  Cek8  appears  to  be  expressed  at 
higher  levels  in  the  somites  than  in  the  neural  tube, 
whereas Cek9 immunoreactivity is more prominent in the 
neural tube. In contrast to Cek9 and Cek8, Cek5 appears 
evenly expressed at low levels in the posterior region of 
the  embryo (Fig.  5  C),  similar  to  its  mouse homologue 
Nuk (Henkemeyer et al.,  1994). In the hindbrain region, 
the  expression  patterns  of  Cek9  and  Cek8  also  differ. 
While Cek8 immunoreactivity is very prominent in rhom- 
bomeres 3 and 5, the otic vesicle, and the migrating neural 
crest cells adjacent to rhombomere 5 (Fig. 5 D), Cek9 im- 
munoreactivity is evenly distributed (Fig. 5 E). 
Immunoperoxidase labeling  of frozen sections  of em- 
bryos 4-8 d old revealed similar levels of Cek9 immunore- 
activity in most tissues (not shown). In the 10-d embryo, 
Cek9 can be detected in all the tissues that we examined 
by immunoblotting, except for the blood (Fig. 6). Cek9 is 
present in the liver (at very low levels), gizzard, thigh, and, 
at  higher  levels,  the  intestine  and  brain.  Cek9  is  most 
highly expressed in the developing retina. 
To determine whether Cek9 plays a role in the develop- 
ment of retinotectal projections, as has been proposed for 
Figure  3.  Developmental 
regulation  of  Cek9  expres- 
sion in the early embryo. Ex- 
tracts  from  embryos  at  the 
days of development in ovo 
indicated  at the bottom and 
containing equal amounts  of 
protein were loaded in each 
lane  and  probed  with  anti- 
Cek9  antibodies.  The  posi- 
tions  of  molecular  mass 
markers, in kD, are indicated 
at left. 
The Journal  of Cell Biology,  Volume 135, 1996  786 Figure 4.  Expression pattern of Cek9 in the chicken embryo at 2 d of development in ovo. Dorso-lateral view of a 2-d chicken embryo 
stained with anti-Cek9 antibodies (A) or preimmune serum (B) by whole-mount immunohistochemistry. Hi, hindbrain; He, heart; So, 
somites; and NT, neural tube. The arrow next to "So" marks the most recently formed somite. 
several other Eph-related receptors (Cheng et al.,  1995; 
Drescher et al., 1995; Holash and Pasquale, 1995; Kenny 
et al., 1995), its spatial distribution in the visual system was 
examined by immunohistochemistry. Cek9 is  evenly ex- 
pressed throughout the thickness of the undifferentiated 
chicken retina (not shown). After the retina differentiates 
into distinct layers, Cek9 becomes most concentrated in the 
inner plexiform layer and the nerve fiber layer (Fig. 7 A and 
8 A), both of which contain neuronal processes (Fig. 8 B). 
Consistent with the distribution of the Cek9 protein, Cek9 
mRNA  is detected in the retinal ganglion cell layer and 
the inner portion of the inner nuclear layer, which contains 
amacrine  neurons.  Neurons  in  these  layers extend pro- 
cesses  in  the  nerve fiber layer and  the  inner  plexiform 
layer, where the Cek9 protein is concentrated. In addition 
to the nerve fiber layer of the retina, Cek9 immunoreactiv- 
ity outlines all other structures in the visual pathway that 
contain the axons of retinal ganglion cells: the optic nerve, 
optic tract, and stratum opticum of the optic tectum (Fig. 
7  A).  The  distribution  of Cek9  in  the  retina  and  optic 
nerve is similar to that of Cek5, except that Cek5 is con- 
centrated in the ventral aspect of the chicken retina and in 
only about half of the optic nerve, as previously reported 
(Fig. 7  C and Holash and Pasquale,  1995).  Unlike Cek5, 
Cek9 appears  to be evenly distributed along the dorsal- 
ventral axis of the retina. To determine whether Cek9 is 
expressed in a gradient along the anterior-posterior axis of 
the retina (Holash and Pasquale, 1995), extracts from the 
anterior and the posterior retina were probed with anti- 
Cek9 antibodies. As shown in Fig. 9, Cek9 appears evenly 
distributed along the anterior-posterior axis. In the same 
samples  the  expression of another Eph  receptor,  Cek4, 
was examined for comparison. As expected (Cheng et al., 
1995), Cek4 is concentrated in the posterior retina (Fig. 9). 
Temporal changes in  Cek9 expression throughout de- 
velopment were examined in the whole embryo as well as 
in a number of tissues (Fig. 10 A). In the whole embryo, 
Cek9 expression continues to increase between E3 and E4 
and remains approximately constant thereafter. In the ce- 
rebrum, Cek9 expression is high at the earliest time exam- 
ined (embryonic day 6), and it only slightly decreases dur- 
ing development. In  the cerebellum, Cek9 expression is 
lower than in the cerebrum and does not change substan- 
tially between embryonic days 10 and 20, while it is some- 
what lower at embryonic day 8. In the neural retina, Cek9 
expression is high and decreases somewhat between em- 
bryonic days 8 and 19. Finally, in the skeletal muscle of the 
thigh, Cek9 is expressed highly between embryonic days 7 
and 15, and at much lower levels at later stages. 
Tyrosine Phosphorylation  of Cek9 during 
Embryonic Development 
The results shown in Fig. 10 A  indicate that in many tis- 
sues, Cek9 expression does not change substantially dur- 
ing development. We next examined temporal changes in 
Cek9  phosphorylation  on  tyrosine  (Fig.  10  B).  Upon 
ligand binding, receptor protein-tyrosine kinases typically 
dimerize and autophosphorylate (van der Geer et al., 1994). 
This is thought to correlate with their catalytic activation, 
Soans et al. The Eph-related Receptor Cek9 in Development  787 Figure 5.  Expression patterns of Cek9, Cek8, and Cek5 in the chicken embryo at 2 d of development in ovo. The top three panels show 
dorsal views of the posterior regions of embryos stained with anti-Cek9 (A), anti-Cek8 (B), and anti-Cek5 (C) antibodies. The bottom 
three panels show lateral views of the anterior regions of embryos stained with anti-Cek9 (D) and anti-Cek8 (E) antibodies and anti- 
Cek9 antibodies that had been preincubated with the peptide antigen as a control (F). So, somites; PS, primitive streak; Ov, otic vesicle; 
3, rhombomere 3; 5, rhombomere 5. The arrow next to SO in A, B, and C marks the most recently formed somite. The somite that is 
condensing posterior to that is prominently labeled with anti-Cek8 antibodies in B, but not with anti-Cek9 (A) or anti-Cek5 (C) antibod- 
ies. The arrow in D and E marks the migrating neural crest cells adjacent to rhombomere 5. 
The Journal of Cell Biology, Volume 135, 1996  788 Figure 6.  Cek9 expression  in chicken embryonic tissues at em- 
bryonic day 10. Tissue extracts containing equal amounts of pro- 
tein were loaded in each lane. The immunoblot was probed with 
antibodies to Cek9. Br, brain; Re, retina; Le, lens; Lu, lung; He, 
heart; Li, liver; In, intestine;  Gi, gizzard; Th, skeletal muscle of 
the thigh; BI, blood. The positions of molecular mass markers, in 
kD, are indicated at left. 
which results in the phosphorylation on tyrosine of target 
molecules. We determined the extent of Cek9 phosphory- 
lation  on  tyrosine in  vivo by immunoprecipitation  with 
anti-Cek9 antibodies, followed by SDS-PAGE and immu- 
noblotting  with  antiphosphotyrosine  antibodies.  Protein 
tyrosine phosphorylation of Cek9  in  the  whole  embryo 
was examined from day 4  to day 10.  Phosphorylation of 
Cek9 was detected at every stage, with somewhat higher 
levels between days 7 and 9. Protein tyrosine phosphoryla- 
tion of Cek9 in the cerebrum is high between embryonic 
days 5 and 11, and it decreases to barely detectable levels 
at  later  developmental  stages.  In  the  cerebellum,  Cek9 
phosphorylation on tyrosine is low and only detectable un- 
til embryonic day 11. Cek9 phosphorylation is highest in 
the retina, particularly before embryonic day 13. Cek9 is 
phosphorylated on tyrosine in the retina at every develop- 
mental stage examined. In the skeletal muscle of the thigh, 
Cek9 is also phosphorylated on tyrosine at every develop- 
mental stage that was examined, but at embryonic day 19 
the level of phosphorylation is barely detectable. 
Thus, Cek9 is phosphorylated on tyrosine in all the tis- 
sues examined during at least certain periods of embryonic 
development. Since our previous data indicated that other 
Eph-related  receptors  are  not  substantially  phosphory- 
lated on tyrosine in most embryonic tissues  (Pasquale et 
al., 1994; Soans et al., 1994), we compared the phosphory- 
lation of Cek9 in the 8-d embryo with that of Cek4, Cek5, 
and Cek8, other receptors of the Eph subfamily that are 
closely related to Cek9. Each receptor was immunoprecip- 
itated with 20 Ixg of specific antibodies and probed by im- 
munoblotting  with  antiphosphotyrosine  antibodies.  The 
results, shown in Fig 11 A, reveal that in both the body tis- 
sues and the brain of the 8-d chicken embryo, Cek9 is the 
most highly phosphorylated of the four Eph-related recep- 
tors examined, suggesting that it is the most catalytically 
active. Phosphorylation on tyrosine of Cek4 and Cek8 was 
low in the 8-d embryonic brain and not detectable in the 
body tissues.  Phosphorylation of Cek5  was  very low  in 
both brain and body tissues at embryonic day 8. 
To determine the fraction of Cek9 molecules that  are 
phosphorylated on tyrosine in vivo in the 10-d embryonic 
retina, a tissue in which the level of Cek9 phosphorylation 
on tyrosine is relatively high (Fig. 10 B), Cek9 was immu- 
noprecipitated  with  anti-Cek9  antibodies.  The  resulting 
immunoprecipitate  was  reimmunoprecipitated  using  an- 
tiphosphotyrosine antibodies to separate the Cek9 mole- 
cules  that  were  phosphorylated  on  tyrosine from  those 
that were not. The nonphosphorylated Cek9 remained in 
the  supernatant  because it is  not  recognized by the  an- 
tiphosphotyrosine antibodies.  It was  then reimmunopre- 
cipitated using  anti-Cek9  antibodies.  Immunoblotting of 
the two immunoprecipitates with anti-Cek9 antibodies al- 
lowed the proportion of phosphorylated and nonphosphor- 
ylated Cek9 to be compared (Fig 11 B). While the fraction 
of Cek9 that is  phosphorylated on tyrosine is  easily de- 
tected  with  antiphosphotyrosine  antibodies  (left  panel, 
lane  Y),  it cannot be detected with anti-Cek9 antibodies 
(right panel,  lane  Y)  unless the film is overexposed (not 
shown).  This indicates  that  only a  small  fraction of the 
Cek9 molecules are phosphorylated on tyrosine in vivo, as 
it would be expected since phosphorylation on tyrosine of 
receptor protein-tyrosine kinases  after ligand  binding  is 
typically transient. 
Discussion 
Cek9 was, until now, one of the least characterized of the 
Eph-related kinases.  Here we  report the full coding se- 
quence of Cek9. Similar to all other members of the Eph 
subfamily, Cek9 is comprised of an extracellular ligand- 
binding domain containing 20 conserved cysteines and two 
fibronectin type III repeats, a  single membrane-spanning 
segment, and a cytoplasmic region containing a conserved 
kinase domain. Based on its amino acid sequence, Cek9 
belongs to a  subgroup within the Eph subfamily that in- 
cludes Cek5/Nuk/HEKS, Cek6/Elk, Cekl0/HEK2, and HTK 
(Sajjadi and Pasquale, 1993; Fox et al., 1995). Homologues 
of the Cek9 gene have not yet been identified in other spe- 
cies. 
mRNAs  encoding at least two isoforms of Cek9 exist. 
The variant mRNA that we have designated Cek9' lacks a 
recognizable signal peptide in the predicted amino acid se- 
quence. This is due to the presence of a  64-bp insertion 
near the 5' end, which causes a shift in the reading frame. 
Since the insertion is precisely in the position where an in- 
tron is located in the related receptor Cek5 (Connor and 
Pasquale, 1995), it is likely that the two forms of Cek9 are 
the result of alternative splicing. Although variant forms 
have been reported for other Eph-related receptors (Con- 
nor and  Pasquale,  1995  and references therein), none is 
similar to Cek9'. However, there are other examples of re- 
ceptor tyrosine kinase isoforms that lack a signal sequence 
for membrane translocation. These include variant forms 
of TrkC (Garner and Large, 1994), fibroblast growth fac- 
tor receptor 1,  (Hou et al.,  1991)  and v-erb-B  (Hayman 
and Beug, 1984; Privalsky and Bishop, 1984).  Despite the 
prediction that these variants are likely to be localized to 
the cytoplasm, v-erb-B  is expressed as a  transmembrane 
protein. In contrast, it is not known whether the TrkC, fi- 
broblast growth factor receptor 1, and Cek9 variant tran- 
scripts  are  efficiently  translated  into  protein.  Because 
Cek9, after cleavage of the signal peptide, and Cek9' are 
expected to have the same sequence (with the exception of 
the two initial amino acids of Cek9'), we could not distin- 
Soans et al. The Eph-related Receptor Cek9 in Development  789 Figure 7.  Expression patterns of Cek9 in the visual pathway of the embryonic day 12 chicken embryo. (A) Immunoperoxidase labeling 
with anti-Cek9 antibodies resulted in the labeling of the ganglion cell processes.  The entire pathway of the ganglion cell axons is labeled, 
including the nerve fiber layer (arrowhead), optic nerve (on), optic tract (or), and stratum opticum of the tectum (so). Strong immunore- 
activity is also observed in the inner plexiform layer of the retina (arrow). (B) The staining observed in A is abolished by preincubation 
of the anti-Cek9 antibodies with the GST fusion protein used as the antigen. (C) Similar  to Cek9, Cek5 immunoreactivity is concen- 
trated in the inner plexiform layer and nerve fiber layer of the retina. Unlike Cek9, Cek5 immunoreactivity is concentrated in only a 
portion of the optic nerve. Bar: (B) 300 I~m. 
guish  Cek9'  from  Cek9  with  our  antibodies  nor  assess 
whether the Cek9' protein is expressed. However, it should 
be  noted  that  six  initial  ATG  sequences  are  located  up- 
stream of the predicted Cek9' initiation codon (compared 
to two in the Cek9 cDNA). Translation starting from any 
of these ATGs would produce short polypeptides and in- 
hibit the translation of Cek9' (Kozak, 1992). 
To fully appreciate  the  importance  of the  Eph-related 
receptors in development, their distribution patterns must 
be compared. This allows potential roles of these receptors 
to be hypothesized and permits the assessment of whether 
members  of the  Eph subfamily are  likely to function re- 
dundantly  or  uniquely.  Cek9  expression  was  previously 
studied  by  Northern  analysis.  Among  adult  chicken  tis- 
sues, Cek9 mRNA expression is most abundant in the ret- 
ina and thymus (Sajjadi  and Pasquale,  1993).  In the  10-d 
chicken embryo, it was found that  Cek9 mRNA  is  more 
highly expressed in the brain than in body tissues.  In the 
current study we have used specific polyclonal antibodies 
to characterize  the  expression  and  spatial  localization of 
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terns  of  Cek9  protein  and 
mRNA in  the  neural  retina 
of  the  embryonic  day  12 
chicken embryo. (A)  Immu- 
noperoxidase  labeling  with 
the  anti-Cek9  antibodies  re- 
suited in labeling of the inner 
plexiform  layer  (ip)  and 
nerve fiber layer (n  f), shown 
here at higher magnification 
than  in  Fig.  7  A.  The  pig- 
mented  epithelium  (pe)  ap- 
pears  dark because it is pig- 
mented.  (B)  Cresyl  violet 
staining  shows  the  layers  of 
the retina,  such as the inner 
nuclear layer (in) and retinal 
ganglion cell layer (g), which 
consist of cell bodies, and the 
inner  plexiform  layer  and 
nerve fiber layer, which con- 
sist of neuronal processes. (C 
and D) Bright field and dark 
field  photomicrographs,  re- 
spectively,  of retina  probed 
with Cek9 antisense mRNA. 
Cek9 transcripts are concen- 
trated in the retinal ganglion 
cell  layer and the inner por- 
tion  of  the  inner  nuclear 
layer, which contains amacrine cells. Apparent labeling of the pigmented epithelium is nonspecific (compare D and E). (E) Dark field 
photomicrograph of retina probed with Cek9 sense mRNA, as a control. All the panels are at the same magnification; however, differ- 
ences in tissue processing for immunohistochemistry or in situ hybridization experiments are responsible for the apparent different sizes 
of the retinas in the top and bottom panels. In addition, A and B represent sections of the retina close to the optic nerve, and thus con- 
tain a more prominent nerve fiber layer. Bar: (A) 50 p.m. 
the Cek9 protein during development. The widespread ex- 
pression of Cek9 supports its playing roles in multiple de- 
velopmental  processes.  Like  Cek5  and  Cek8,  two  other 
Eph-related  receptors  that  were  previously  examined, 
Cek9 is expressed in the chicken embryo at early stages of 
development (Pasquale, 1991; Pasquale et al., 1994; Soans 
et al., 1994; Ohta et al., 1996). However, the distribution of 
Cek9 in the 2-d embryo suggests that Cek9 has a  distinct 
functional role. Unlike Cek5, both Cek9 and Cek8 exhibit 
a graded distribution in the posterior region of the 2-d em- 
bryo, with higher levels in the more caudal regions of the 
neural tube and in the more posterior somites. A  similarly 
Figure 9.  Cek9 and Cek4 ex- 
pression  in the  anterior  (A) 
and posterior (P) embryonic 
day 8 chicken retina. Extracts 
of anterior and posterior ret- 
ina containing equal amounts 
of protein were probed with 
antibodies to Cek9 or Cek4. 
The  positions  of  molecular 
mass markers, in kD, are in- 
dicated at left. 
graded, but more restricted distribution in the developing 
somites was previously observed for the mRNA encoding 
Sek-1, the mouse homolog of Cek8 (Nieto et al., 1992). A 
similar expression pattern of the Cek8 protein was also de- 
tected in the stage 12 chicken embryo (Irving et al., 1996; 
Ohta et al., 1996). Because the posterior structures of the 
developing  chicken  embryo are  less  mature,  the  expres- 
sion pattern  of Cek9 suggests a  function in the early pat- 
terning of neural tube and somites. Although the patterns 
of expression of Cek9 and Cek8 are partially overlapping, 
the Cek9 domain of expression is more anterior than that 
of Cek8, indicating a  later onset of expression and a  later 
downregulation in the somites and early neural tube. Fur- 
thermore,  in  contrast  to  Cek8,  Cek9  is  expressed  more 
prominently  in  the  neural  tube  than  in  the  somites.  Its 
even  distribution  in  the  developing hindbrain  suggests  a 
role for Cek9 different from regulating the segmental pat- 
terning  of this  structure,  at  least  in  the  2-d  chicken em- 
bryo. In contrast, roles in patterning of the hindbrain have 
been  attributed  to  several  other  Eph-related  receptors 
(Becker et al.,  1994; Ganju et  al.,  1994; Ruiz et al.,  1994; 
Henkemeyer et al., 1994; Ellis et al., 1995; Xu et al., 1995). 
At all  developmental  stages examined,  Cek9 is promi- 
nently expressed in structures  of the optic pathway (Figs. 
6-9), suggesting a special involvement in the formation of 
the visual system. It has been recently reported that Cek4, 
Cek5/QEK5,  Ebk,  and  several  of  the  ligands  for  Eph- 
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regulation  of  Cek9  expres- 
sion and phosphorylation on 
tyrosine.  (A) Whole embryo 
extracts  or  tissue  extracts 
(cerebrum, cerebellum,  neu- 
ral retina,  and skeletal mus- 
cle  of the  thigh)  containing 
equal  amounts  of  protein 
were loaded in each lane and 
probed with  anti-Cek9  anti- 
bodies.  (B)  Whole  embryo 
extracts  or  tissue  extracts 
were  subjected  to  immuno- 
precipitation  with  equal 
amounts  of  anti-Cek9  anti- 
bodies and analyzed by blot- 
ting  with  antiphosphoty- 
rosine  antibodies  (PTYR), 
followed  by  reblotting  with 
anti-Cek9  antibodies  (Cek9). 
The lanes  labeled  Ig in  the 
"Whole embryo" and  "Ret- 
ina" panels also contain  con- 
trol  immunoprecipitations 
using  nonimmune  rabbit 
IgG. Days of development in 
ovo are indicated  at the bot- 
tom of each panel.  It should 
be  noted  that  the  levels  of 
Cek9  that were immunopre- 
cipitated in the  experiments 
shown in B do not reflect ex- 
pression  levels,  since  an ex- 
cess  of  tissue  and  limiting 
amounts of antibodies  were 
used  for  the  immmunopre- 
cipitations. 
related receptors exhibit polarized distributions in the ret- 
ina, optic nerve, and/or optic tectum (Cheng et al.,  1995; 
Drescher et al., 1995;  Holash and Pasquale, 1995;  Kenny 
et al.,  1995; Ellis et al., 1995;  Holash, J.A., and E.B. Pas- 
quale,  unpublished  data).  On the basis of these observa- 
tions,  it  was  proposed  that  these  Eph-related  receptors 
and their ligands confer positional information in the vi- 
sual system, thereby regulating the specificity of retinotec- 
tal projections. Cek9 expression is highly enhanced in re- 
gions containing the axonal projections of retinal ganglion 
cells, but its expression does not' appear to be in a gradient. 
This distribution of Cek9 does not support a role in regu- 
lating  retinotectal  specificity;  rather,  it  suggests  a  more 
general function relating to the outgrowth of retinal gan- 
glion cell axons to the optic tectum. However, it cannot be 
excluded that Cek9 functions in the visual pathway by act- 
ing in concert with other Eph-related receptors that have a 
partially overlapping polarized distribution. These include 
Cek5, which is concentrated  in the inner plexiform layer 
and the retinal ganglion cell axons from the ventral retina 
(Pasquale et al., 1994; Holash and Pasquale, 1995), and/or 
Cek4, which is concentrated in the retinal ganglion cell ax- 
ons from the posterior retina (Cheng et al., 1995). 
The  widespread  expression of Cek9 outside  the  visual 
system suggests  multiple  functions  during  development. 
For example, the downregulation of Cek9 expression in the 
skeletal muscle of the thigh coincides with the time of in- 
creased expression of muscle-specific proteins (Pasquale, 
1991)  and  suggests that  Cek9 functions in muscle before 
terminal differentiation. Further work will be required to 
establish whether activation of Cek9, like that of other re- 
ceptor protein-tyrosine kinases (for review see Hauschka, 
1994), interferes with skeletal muscle differentiation. 
The differences in their spatiotemporal expression pat- 
terns suggest that Cek5, Cek8, and Cek9 each play unique 
roles  in  development.  However,  the  feature  that  most 
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tors is its enhanced phosphorylation on tyrosine in embry- 
onic tissues. Therefore, in many tissues at certain develop- 
mental stages, a fraction of the Cek9 present is likely to be 
activated.  Although the  fraction  of the  Cek9  molecules 
that are phosphorylated on tyrosine in vivo at any time is 
small, it is likely to be significant. Because uncontrolled ty- 
rosine kinase activity may have pathological consequences 
(Bishop, 1991),  protein tyrosine phosphorylation appears 
to be tightly regulated in normal tissues. The in vivo acti- 
vation (phosphorylation on tyrosine) of several other Eph- 
related receptors that we have examined is less extensive 
than that of Cek9, suggesting a particularly widespread in- 
volvement of Cek9 in the processes of embryogenesis. The 
high  Cek9  phosphorylation on  tyrosine  during  the  first 
half of development  may implicate  it  in  developmental 
processes such as cell division or migration. 
Phosphorylation on tyrosine of receptor protein-tyrosine 
kinases is typically caused by their interaction with an ex- 
tracellular ligand. Hence, the pattern of Cek9 phosphory- 
lation on tyrosine that we have observed implies that the 
Cek9 ligand is widely expressed and its pattern of expres- 
sion must at least partially overlap with that of Cek9 dur- 
ing the first half of chicken embryonic development. The 
decrease in Cek9 tyrosine phosphorylation during the sec- 
ond part of embryonic development, which was observed 
in all tissues examined, although to different extents, may 
result from the decreased expression of the Cek9 ligand(s). 
It is  also possible  that  receptor and ligand may become 
confined to distinct regions, as would be required if Cek9 
is  involved in  establishing  boundaries  between  adjacent 
anatomical compartments. Such a role has been proposed 
for other Eph receptors (Cheng et al.,  1995; Drescher et 
al.,  1995; Xu et al., 1995).  Alternatively, the persistent ex- 
pression, but low activation levels, of Cek9 at later devel- 
opmental stages may indicate a function that is not depen- 
dent on catalytic activation. Although Cek9 is most closely 
related to Cek5, Cek6/Elk, and Cekl0, a ligand which acti- 
vates  the  latter  three  receptors  does  not  bind  to  Cek9 
(Brambilla et al.,  1995),  suggesting the existence of a dis- 
tinct Cek9 ligand. Interestingly, the extracellular domain 
of Cek9 is 57% identical at the amino acid level to that of 
Cek5, 53% identical to that of Cek6/Elk, and 48% identi- 
cal to that of Cekl0, whereas the extracellular domains of 
Cek5, Elk, and Cekl0 are between 63 and 68% identical to 
each other. Amino acid sequence differences between the 
extracellular  domain of Cek9  and  those  of Cek5,  Cek6/ 
Elk, and Cekl0, which bind the same ligand, are presum- 
Figure  11.  Comparison  of the  in  vivo phosphorylation  on ty- 
rosine of Cek9, Cek8, Cek5, and Cek4 and extent of in vivo Cek9 
phosphorylation  on tyrosine. (A) Cek9, Cek8, Cek5, and  Cek4 
(lanes 9, 8, 5, and 4, respectively) were immunoprecipitated from 
extracts of 8-d embryonic body tissues and 8-d embryonic brain 
using approximately equal amounts of anti-Cek9, anti-Cek8, anti- 
Cek5,  or  anti-Cek4  antibodies.  The  immunoprecipitates  were 
probed with antiphosphotyrosine  antibodies  (a-PTYR) and re- 
probed with a mixture of antibodies to the four receptors (a-kinases). 
The use of a mixture of antibodies allowed the simultaneous visu- 
alization of all four receptors, but caused increased background. 
(B)  The  tyrosine phosphorylated  (lane  Y)  and  nonphosphory- 
lated (lane 9) forms of Cek9 were immunoprecipitated separately 
from retina extracts at embryonic day 10, as described in the Ma- 
terials and Methods, and both were probed with either antiphos- 
photyrosine  antibodies  (a-PTYR) or  anti-Cek9  antibodies  (a- 
Cek9). The lack of signal (at this level of exposure)  in the lane 
containing Cek9 immunoprecipitated  with antiphosphotyrosine 
antibodies  and  probed  with anti-Cek9  antibodies  (right  panel, 
lane Y) indicates that only a small fraction of the Cek9 molecules 
are phosphorylated on tyrosine in the retina at embryonic day 10. 
However, longer exposure times allow detection of a band in this 
lane. The positions of molecular mass markers, in kD, are indi- 
cated at left. 
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The identification of physiological ligand(s) for Cek9 will 
greatly facilitate the study of the role of Cek9 in develop- 
mental processes. 
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